UBS Group »

Sonnet Biotherapeutc Hldng I shares owned by UBS Group

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3k 277 4.58
2025-06-30 $8.3k 6.7k 1.24
2025-03-31 $187 141 1.33
2024-12-31 $3 3 1.33